Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

Task Force on MSA Criteria Revision

Gregor Wenning
Gregor Wenning
Chair
Horacio Kaufmann, MD, FAAN
Horacio Kaufmann
Chair
 

MDS Staff Liaison: Amber Flatland

Task Force Purpose
Multiple system atrophy (MSA) is diagnosed typically half way through its clinical course according to the widely accepted revised consensus criteria in 2008. A validation exercise of the second consensus criteria showed a sensitivity for MSA diagnosis of 41% for possible and 18% for probable at first neurological visit, whereas at last visit these figures were 92% and 63% respectively.

With an anticipated emergence of novel disease modifying treatments, it is important to increase the specificity and overcome the poor sensitivity of the existing criteria in early stages. Therefore revisiting the current set of diagnostic criteria for MSA becomes a research priority.

The MSA Criteria Revision Task Force will aim to achieve a revision of the second consensus criteria for the diagnosis of MSA.
 

Members:
    
Anthony Lang
    Daniela Berg
    Glenda Halliday
    Jalesh Panicker
    Niall Quinn
    Pietro Cortelli
    Phillip Low
    Roy Freeman
    Ryuji Sakakibara
    Shoji Tsuji
    Wassilios Meissner
    Werner Poewe

Expert Consultants (Non-Voting):
  
 Günter Hoglinger
    Irene Litvan
    Maria Theresa Pellecchia
    Maria Stamelou
    Eduardo Tolosa

Neuropathology Support Team (Non-Voting):
    Helen Ling
    Yasuo Miki
    Thomas Warner

Junior Executive Team (Non-Voting):
    Iva Stankovic
    Giovanna Calandra Bounaura
    Alessandra Fanciulli
    Florian Krismer
    Alberto Palma
    Luca Vignatelli
 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice